Phosphoric Acid

Phosphoric Acid

SCHEMBL2483060

CCCCc1[nH]cc[n+]1C.O=P([O-])(O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GGPS1 O95749 9/20 0.35
FDPS P14324 11/20 0.32
ENPP2 Q13822 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL30381493 0.95 GGPS1 (0.32) GGPS1
Phosphoric Acid SCHEMBL7993142 0.94 GGPS1 (0.41) GGPS1FDPSENPP2
SCHEMBL2327534 0.91 GGPS1 (0.30) GGPS1
SCHEMBL15922028 0.89
Phosphoric Acid SCHEMBL31027757 0.89 GPR84 (0.38) GGPS1FDPSENPP2
SCHEMBL3470871 0.87
SCHEMBL107551 0.87 HRH3 (0.34)
Diethyl Hydrogen Phosphate SCHEMBL6005556 0.85 LMNA (0.31)
SCHEMBL535081 0.85 HRH3 (0.30)
SCHEMBL535453 0.85 HRH3 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558102-A1 SYNERGISTIC INTERACTION OF AT LEAST ONE VITAMIN E COMPONENT AND TYROSINASE INHIBITORS FOR DERMATOLOGICAL APPLICATIONS Davos Life Science Pte. Ltd. (SG) 2013-02-20 EP disclosed
WO-2011129765-A1 SYNERGISTIC INTERACTION OF AT LEAST ONE VITAMIN E COMPONENT AND TYROSINASE INHIBITORS FOR DERMATOLOGICAL APPLICATIONS DAVOS LIFE SCIENCE PTE. LTD. (SG) 2011-10-20 WO disclosed
EP-2376448-A2 IMPROVED METHOD FOR THE PREPARATION OF 1-ACETYL-6-AMINO-3,3-DIMETHYL-2,3-DIHYDROINDOLE Amgen, Inc (US) 2011-10-19 EP disclosed
WO-2010071828-A2 IMPROVED METHOD FOR THE PREPARATION OF 1-ACETYL-6-AMINO-3,3-DIMETHYL-2,3-DIHYDROINDOLE AMGEN INC. (US) 2010-06-24 WO disclosed
EP-1456435-A4 ELECTROCHEMICAL PROCESS FOR PRODUCING IONIC LIQUIDS SACHEM INC (US) 2006-10-25 EP disclosed
EP-1456435-A1 ELECTROCHEMICAL PROCESS FOR PRODUCING IONIC LIQUIDS SACHEM, INC. (US) 2004-09-15 EP disclosed
WO-2003046257-A1 ELECTROCHEMICAL PROCESS FOR PRODUCING IONIC LIQUIDS SACHEM, INC. (US) 2003-06-05 WO disclosed